Rafael Holdings Inc - Ordinary Shares - Class B

NYSE:RFL   9:32:23 AM EDT
51.41
-0.55 (-1.06%)
Divestitures / Spin-offs, Exchange Changes, Mergers / Acquisitions

Rafael Holdings Announces Strategic Merger With Rafael Pharmaceuticals To Form A Focused Late-Stage Clinical Oncology Company

Published: 06/21/2021 11:48 GMT
Rafael Holdings Inc - Ordinary Shares - Class B (RFL) - Rafael Holdings Announces Strategic Merger With Rafael Pharmaceuticals to Form a Focused Late-stage Clinical Oncology Company.
Rafael Holdings - Will Acquire for $30 Million Remaining Membership Interest in Altira Capital & Consulting, Llc That It Does Not Already Own.
Rafael Holdings Inc - Merged Company Will Retain Rafael Pharmaceuticals Name and Rafael Holdings' Listing on New York Stock Exchange.
Rafael Holdings - Co, Units Currently Own a Majority of Outstanding Stock of Rafael Pharmaceuticals and a Significant Stake on a Fully-diluted Basis.
Rafael Holdings Inc - Howard Jonas Will Serve As Chairman, Ameet Mallik Will Serve As Ceo.
Rafael Holdings - Holders of Rafael Pharma Capital Stock to Get Shares of Co's Class B Stock Amounting to About 48% of Outstanding Capitalization of Co.
Rafael Holdings - Will Consummate a Capital Raise of at Least $50 Million Less Potential Proceeds From Sale of Certain Real Estate Assets.